Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
about
Characterizing autism spectrum disorders by key biochemical pathways.DNA methylation in mammalsFragile X syndrome as a rare disease in China - Therapeutic challenges and opportunitiesPAK in Alzheimer disease, Huntington disease and X-linked mental retardationAMH in women with diminished ovarian reserve: potential differences by FMR1 CGG repeat levelFrom FMRP function to potential therapies for fragile X syndrome.Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserveFragile X Syndrome: Prevalence, Treatment, and Prevention in ChinaAGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmission.Distribution of AGG interruption patterns within nine world populations.The Fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice.Fragile X syndrome screening in Chinese children with unknown intellectual developmental disorder.A comparison of family financial and employment impacts of fragile X syndrome, autism spectrum disorders, and intellectual disabilityFinding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissueLength of FMR1 repeat alleles within the normal range does not substantially affect the risk of early menopause.The FMR1 CGG repeat test is not a candidate prescreening tool for identifying women with a high probability of being carriers of BRCA mutationsThe impact of genetics on future drug discovery in schizophrenia.Non-LTR retrotransposons and microsatellites: Partners in genomic variationFrequency of FMR1 premutation carriers and rate of expansion to full mutation in a retrospective diagnostic FMR1 Korean sample.Alterations in the Sp1 binding and Fmr-1 gene expression in the cortex of the brain during maturation and aging of mouse.Fragile X syndrome screening in pregnant women and women planning pregnancy shows a remarkably high FMR1 premutation prevalence in the Balearic Islands.ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics.Platelets as a surrogate disease model of neurodevelopmental disorders: Insights from Fragile X Syndrome.The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency.Incidence of Fragile X syndrome in Ireland.Curvilinear Association Between Language Disfluency and CGG Repeat Size Across the Normal, Intermediate, and Premutation Range
P2860
Q26781645-0D2AFA11-27F4-4FBE-9D27-76A5AE9736B1Q26852141-31C883FA-436A-4B19-A63A-4895187AD6E7Q26863615-03435B6B-9885-4D5D-AE76-561EDE8B04A0Q28279479-98583120-F264-453A-8782-4CBA67E49FFBQ30370644-4CE5F22E-6693-4ED2-AE4A-5EBC0C9A760BQ30410502-E4093744-0CB6-461A-B761-9D2C2809A053Q30412537-44640F18-6A65-4F0A-B2BA-D4B95DC210BDQ33766106-4901A5B9-DF9F-4D3C-B1E6-DBDFA047CE58Q34020825-14A26160-F385-4E56-A9B4-22895F2BBB5AQ34983517-17F56B49-D284-4D0A-9ADF-23B45E70403DQ35234080-47B2BA4F-C77B-4AE4-BDE0-ADB33D06E6DBQ35691404-21024D3E-C7C6-4A4C-B430-F0DBAE368A82Q35819502-D61ABFFA-2DEE-41D5-8C5A-D5B7ED34D41AQ36925690-49E4D6DE-00D9-4238-BABF-1DB22DC7D990Q37265393-ABCE21B3-ABC3-4CB6-BEC1-A1B19D744011Q37493133-294DFBEA-12DF-4DC0-8909-F3FAD2075790Q38682213-8E3F1236-089A-4AB0-9295-DD193949EF25Q42553221-10A986DD-BA54-4A7D-ABD9-7BE9CCE56511Q43628490-2F4A7936-015F-4594-B730-57CBF1125DC7Q46613683-1860359B-8443-476C-A5A0-114F6179CA32Q47996848-108B9051-A9B5-4100-9144-0B805BD1660AQ48621332-24ACEB41-7C33-4904-A397-FD7986B33A09Q50307674-3F2C1CA1-4594-4B51-A8F8-3A290FB41D45Q50644642-2FB8C64A-C86B-4B26-ADBF-3DEA11F9EF04Q54539525-5683DDC4-BDB1-4D2B-928C-9A3B69295F67Q58705431-FFEFE66E-E959-46BB-8962-3F0B16DA8FEF
P2860
Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
@ast
Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
@en
Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
@nl
type
label
Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
@ast
Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
@en
Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
@nl
prefLabel
Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
@ast
Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
@en
Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
@nl
P2860
P3181
P1476
Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
@en
P2093
Emmanuel Peprah
P2860
P304
P3181
P356
10.1111/J.1469-1809.2011.00694.X
P407
P577
2012-03-01T00:00:00Z